EQUITY RESEARCH MEMO

EndoTheia

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

EndoTheia, Inc. is a medical device company developing next-generation steerable tools for flexible endoscopy. Founded in 2020, the company leverages proprietary micromanufacturing techniques to create miniaturized instruments that enhance dexterity and visualization during endoscopic procedures. Current endoscopic tools are limited by rigid or poorly articulated designs, which constrain maneuverability in tight anatomical spaces. EndoTheia's devices are designed to integrate seamlessly with standard endoscopes, enabling independent tool motion at millimeter scales without disrupting clinical workflows. This technology aims to improve therapeutic outcomes in gastrointestinal, pulmonary, and other minimally invasive interventions. The company is currently in a development stage, with a focus on achieving regulatory clearance and establishing commercial partnerships. EndoTheia's approach addresses a significant unmet need for more precise and adaptable endoscopic instruments, positioning it for growth in the expanding endoscopy market.

Upcoming Catalysts (preview)

  • Q4 2026FDA 510(k) clearance for initial steerable tool70% success
  • Q3 2026Strategic partnership with major endoscope OEM50% success
  • Q2 2026Series A or B funding round80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)